These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8013782)

  • 1. Altered gene expression of growth factors and their receptors during esophageal tumorigenesis.
    Jankowski J
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D40-5. PubMed ID: 8013782
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth factors and their receptors in development.
    Adamson ED
    Dev Genet; 1993; 14(3):159-64. PubMed ID: 8395365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the TP53 tumor suppressor gene in malignant transformation of Barrett esophagus].
    Ferec C; Audrezet MP; Mercier B; Robaszkiewicz M
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D46-51. PubMed ID: 8013783
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.
    Chang JT; Katzka DA
    Arch Intern Med; 2004 Jul; 164(14):1482-8. PubMed ID: 15277277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of the analysis of DNA cellular content by flow cytometry in Barrett esophagus].
    Robaszkiewicz M; Hardy E; Volant A
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D35-9. PubMed ID: 8013781
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular basis of esophageal cancer development and progression.
    Denlinger CE; Thompson RK
    Surg Clin North Am; 2012 Oct; 92(5):1089-103. PubMed ID: 23026271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barrett's esophagus: the long and the short of it.
    Lewis JD
    Gastroenterology; 2000 Oct; 119(4):1165-6. PubMed ID: 11040204
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides.
    Normanno N; Bianco C; Damiano V; de Angelis E; Selvam MP; Grassi M; Magliulo G; Tortora G; Bianco AR; Mendelsohn J; Salomon DS; Ciardiello F
    Clin Cancer Res; 1996 Mar; 2(3):601-9. PubMed ID: 9816209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's esophagus: the biology of neoplastic progression.
    Neshat K; Sanchez CA; Galipeau PC; Levine DS; Reid BJ
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D71-6. PubMed ID: 8013790
    [No Abstract]   [Full Text] [Related]  

  • 10. APC gene alterations in Barrett's metaplasia are implicated at an early stage in the carcinogenesis of esophageal adenocarcinoma.
    Fein M
    Am J Gastroenterol; 1997 Feb; 92(2):359-60. PubMed ID: 9040229
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
    Jankowski J; Hopwood D; Pringle R; Wormsley KG
    Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmitogenic actions of growth factors: an integrated view of their role in intestinal physiology and pathophysiology.
    Uribe JM; Barrett KE
    Gastroenterology; 1997 Jan; 112(1):255-68. PubMed ID: 8978367
    [No Abstract]   [Full Text] [Related]  

  • 13. [From Barrett esophagus to adenocarcinoma: can the dangers of natural history be overcome?].
    Robaszkiewicz M
    Gastroenterol Clin Biol; 1996; 20(5 Pt 2):B89-97. PubMed ID: 8761127
    [No Abstract]   [Full Text] [Related]  

  • 14. Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis.
    von Rahden BH; Stein HJ; Feith M; Pühringer F; Theisen J; Siewert JR; Sarbia M
    Mol Carcinog; 2006 Oct; 45(10):786-94. PubMed ID: 16921482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular biology of esophageal adenocarcinoma.
    Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
    J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
    Yacoub L; Goldman H; Odze RD
    Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
    Tørring N; Jørgensen PE; Sørensen BS; Nexø E
    Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the real roles of different erbB proteins in Barrett's Esophagus.
    Chiba T
    Digestion; 2004; 70(2):93-4. PubMed ID: 15375337
    [No Abstract]   [Full Text] [Related]  

  • 19. [New approaches to antitumor therapy: the use of preparations acting on processes regulated by epidermal and/or alpha-transforming growth factors].
    Kushlinskiĭ NE; Gershteĭn ES
    Eksp Klin Farmakol; 1996; 59(1):74-80. PubMed ID: 8704642
    [No Abstract]   [Full Text] [Related]  

  • 20. Roles of transforming growth factor-alpha and epidermal growth factor in chick limb development.
    Dealy CN; Scranton V; Cheng HC
    Dev Biol; 1998 Oct; 202(1):43-55. PubMed ID: 9758702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.